Examkin

Soru

Zorluk: OrtaDiagnostic Workup and Test Sequencing

A 48-year-old male presents to the clinic complaining of excessive sweating, diffuse joint pain, and a gradual increase in his shoe size over the past three years. He also mentions that he recently had to have his wedding ring resized because it would no longer fit over his knuckle. On physical examination, his blood pressure is 148/92 mm Hg. He is noted to have coarse facial features, a prominent mandible, macroglossia, and enlarged, doughy hands. The physician strongly suspects an underlying endocrine disorder characterized by hormonal hypersecretion.

Assuming each step confirms the progression of the diagnostic pathway, arrange the following clinical evaluations in the most appropriate sequential order to screen for, confirm, localize, and assess the local complications of this patient's suspected condition.

  1. 1Measurement of serum insulin-like growth factor 1 (IGF-1) concentration
  2. 2Measurement of serum growth hormone (GH) levels following an oral glucose load
  3. 3Magnetic resonance imaging (MRI) of the brain focused on the sella turcica
  4. 4Formal automated perimetry (visual field testing)

Cevap

The correct diagnostic sequence begins with biochemical screening via serum IGF-1, followed by dynamic confirmation using an OGTT with GH measurement, anatomical localization via pituitary MRI, and finally, assessment of local mass effects using formal visual field testing.
The diagnostic workup for acromegaly represents a classic paradigm of endocrinologic test sequencing. Because random growth hormone (GH) levels fluctuate widely due to pulsatile secretion, the workup must begin with serum Insulin-like Growth Factor 1 (IGF-1), which provides a stable, integrated marker of overall GH activity. If the IGF-1 level is elevated (adjusting for age and sex), the diagnosis must be confirmed dynamically with an Oral Glucose Tolerance Test (OGTT). Normal physiology dictates that a glucose load should suppress GH to very low levels; failure to suppress confirms autonomous GH production. Only after this biochemical confirmation is secured should anatomical imaging (MRI of the sella turcica) be pursued. Premature imaging risks discovering a clinically silent pituitary 'incidentaloma,' which could falsely anchor the diagnosis. Finally, once a central mass is confirmed, assessing for local anatomical complications—specifically optic chiasm compression—via formal visual field testing completes the comprehensive diagnostic workup prior to surgical planning.

Adım Adım Çözüm

1
Select the most appropriate initial biochemical screening test.
Measurement of serum IGF-1 concentration.
Growth hormone is secreted in a highly pulsatile manner, making random serum GH levels unreliable. IGF-1 mediates most of the effects of GH and has a long half-life, providing a stable reflection of average GH secretion.
2
Select the definitive dynamic confirmatory test.
Measurement of serum GH levels following an oral glucose load.
In normal physiology, a glucose load suppresses GH secretion. In autonomous hypersecretion (acromegaly), this suppression fails. This test confirms the biochemical diagnosis.
3
Identify the anatomical source of the hypersecretion.
Magnetic resonance imaging (MRI) of the sella turcica.
Greater than 95% of acromegaly cases are caused by a GH-secreting pituitary adenoma. Imaging should only be ordered after biochemical confirmation to avoid the diagnostic confusion caused by incidental, non-functioning pituitary microadenomas.
4
Assess for local complications related to the identified anatomical lesion.
Formal automated perimetry (visual field testing).
Pituitary macroadenomas frequently extend suprasellar and compress the optic chiasm. Visual field testing evaluates for neurological deficits (e.g., bitemporal hemianopsia) which can dictate the urgency of surgical intervention.

Anahtar Kavram

The diagnostic sequencing for suspected functional endocrine tumors (such as acromegaly) strictly follows three phases: 1) biochemical screening with a stable marker, 2) dynamic biochemical confirmation, and 3) anatomical localization and complication assessment.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru